Proline

Proline

SCHEMBL1298202

N[C@@H](CS)C(=O)O.O=C(O)[C@@H]1CCCN1.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Proline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.52
SLC7A11 Q9UPY5 1/20 0.52
CPN1 P15169 4/20 0.40
CPB2 Q96IY4 4/20 0.40
NOS2 P35228 2/20 0.38
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
MEN1 O00255 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
DPP4 P27487 1/20 0.36
DPP8 Q6V1X1 1/20 0.36
DPP9 Q86TI2 1/20 0.36
ANPEP P15144 2/20 0.35
ENPEP Q07075 1/20 0.35
PRCP P42785 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Proline SCHEMBL15050063 1.00 PTGS1 (0.52) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL4391659 1.00 PTGS1 (0.52) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL51270 1.00 PTGS1 (0.52) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL28759471 1.00 PTGS1 (0.52) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL15049946 1.00 PTGS1 (0.52) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL51269 1.00 PTGS1 (0.52) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL27699077 1.00 PTGS1 (0.52) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL4398351 0.94 PTGS1 (0.46) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL1675268 0.94 PTGS1 (0.46) PTGS1SLC7A11CPN1CPB2NOS2
Proline SCHEMBL7204958 0.94 PTGS1 (0.46) PTGS1SLC7A11CPN1CPB2NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9546371-B2 Chimeric polynucleotides and polypeptides enabling secretion of a polypeptide of interest in association with exosomes and use thereof for the production of immunogenic compositions CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2017-01-17 US disclosed
WO-2013096346-A1 BISPECIFIC T-CELL ACTIVATOR ANTIBODY DEVELOPMENT CENTER FOR BIOTECHNOLOGY (TW) 2013-06-27 WO disclosed
US-20110268750-A1 CHIMERIC POLYNUCLEOTIDES AND POLYPEPTIDES ENABLING SECRETION OF A POLYPEPTIDE OF INTEREST IN ASSOCIATION WITH EXOSOMES AND USE THEREOF FOR THE PRODUCTION OF IMMUNOGENIC COMPOSITIONS UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES (FR) 2011-11-03 US disclosed